Navigation Links
GenWay Clinical Laboratory receives accreditation from College of American Pathologists

GenWay Biotech, Inc. GenWay Clinical Laboratory, San Diego, California, has been awarded an accreditation by the College of American Pathologists (CAP), based on results of a recent onsite inspection.

The laboratory's director was advised of this national recognition and congratulated for the "excellence of the services being provided." GenWay Biotech Inc. GenWay Clinical Laboratory is one of nearly 7,000 CAP-accredited laboratories nationwide.

The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the federal government as being equal to or more stringent than the government's own inspection program.

During the CAP accreditation process, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine the entire staff's qualifications, the laboratories equipment, facilities, safety program and record, as well as to the overall management of the laboratory. This stringent inspection program is designed to specifically ensure the highest standard of care for all laboratory patients.


Contact: Sue Masaracchia-Roberts
800-323-4040 x7319
GenWay Biotech

Page: 1

Related biology news :

1. General tumor marker test now offered by GenWay clinical laboratory
2. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
3. UAB bone center director wins distinguished service award from clinical pathology society
4. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
5. Magnetic nanotags spot cancer in mice earlier than methods now in clinical use
6. RadMD reaches 150th clinical trial
7. New cancer drug test promises safer and more effective clinical trials
8. IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome
9. Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development
10. Antibody targeting of glioblastoma shows promise in preclinical tests, say Lombardi researchers
11. $20 million NIH grant to transform clinical research at UIC
Post Your Comments:
(Date:10/29/2015)...  The J. Craig Venter Institute (JCVI) policy group ... Biosecurity: Lessons Learned and Options for the Future," which ... Services guidance for synthetic biology providers has worked since ... --> --> Synthetic biology promises great ... pose unique biosecurity threats. It now is easier than ...
(Date:10/29/2015)... NXTD ) ("NXT-ID" or ... the growing mobile commerce market and creator of ... leading marketplace to discover and buy innovative technology ... on StackSocial for this holiday season.   ... a biometric authentication company focused on the growing ...
(Date:10/27/2015)... Calif. , Oct. 27, 2015 Synaptics Inc. ... solutions, today announced that Google has adopted the Synaptics ... touch controller solutions to power its newest flagship smartphones, ... by Huawei. --> ... like Google to provide strategic collaboration in the joint ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... InSphero AG, ... 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... Aregger served on the management team and was promoted to Head of ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW Telbec/ - ProMetic Life ... announced today that Mr. Pierre Laurin , President and ... presentation at the upcoming Piper Jaffray 27 th Annual ... Hotel, on December 1-2, 2015. st , ... for one-on-one meetings throughout the day. The presentation will be ...
(Date:11/24/2015)... Va. , Nov. 24, 2015 ... focused on discovering drugs for metabolic disorders, announced ... to its Board of Directors (BOD). Mr. ... officer of Human Genome Sciences (HGS), and also ... Organization. Jim Powers , Chairman and ...
(Date:11/24/2015)... NEW YORK , November 24, 2015 ... in a European healthcare ... in which the companies will work closely together in identifying ... of unmet medical need. The collaboration is underpinned by a ... LSP fund. This is the first investment by Bristol-Myers Squibb ...
Breaking Biology Technology: